Different lives, one question: how long, and how well
minus10med in Athens treats six recurring patient profiles: the proactive professional, the active retiree, the prevention-minded, the performance seeker, the chronically sleep-deprived and the woman in hormonal transition. Each starts from the same diagnostic baseline, then diverges into a different protocol, cadence and set of priorities.
I perform well and want to stay that way. What should I measure?
The proactive professional is the most common first visitor here, usually somewhere between thirty-eight and fifty-five, and usually arriving with the same sentence: nothing is wrong, but something has changed. Energy is thinner in the afternoon. Recovery from a hard week takes two weekends instead of one.
The work is to measure stress physiology, metabolic flexibility and cognitive baseline before burnout writes the story, and then to protect them with cadence rather than heroics. Cortisol patterns, readiness tracking, VO2 Max and body composition give you a scoreboard that responds to changes in sleep, training and workload within weeks.
The next twenty years are the point. How do I protect them?
The active retiree has time, intent and a very specific enemy: silent loss. Muscle mass, bone density, aerobic capacity and cognitive speed all decline predictably from the sixth decade, a pattern documented in the sarcopenia consensus literature, and all four are measurable long before they become a stumble on a staircase.
Protocols here concentrate on strength and mobility, DEXA-verified bone density, cardiovascular reserve and cognition, backed by nutritional and hormonal correction where indicated. Data replaces hope, and re-testing on an annual cadence keeps the plan honest about which parts are working.
Disease runs in my family. Can I see it coming?
Frequently, yes, and earlier than most people expect. The prevention-minded patient wants risk stratification rather than reassurance, and that means whole exome sequencing for inherited cardiovascular, oncological and neurodegenerative risk, coronary calcium scoring, whole body MRI where indicated, and blood-based early cancer detection panels.
The honest framing is that genetics loads a probability and does not fire it. What sequencing buys you is a surveillance schedule tuned to your actual risk instead of a population average, which is exactly what the VIP AI-Guided Diagnostics day is designed to produce in one sitting.
Recovery is my bottleneck. What can be measured?
The performance seeker already trains well and has usually run out of gains available from more volume. Cardiopulmonary exercise testing gives real training zones rather than estimated ones, oxidative stress analysis shows what a heavy block is costing you, and readiness tracking exposes the mismatch between how hard you trained and how well you recovered.
Regenerative therapies are then tuned to training load: hyperbaric oxygen, PEMF, red and near-infrared light and targeted infusions, all described on the regenerative therapies page, and all bracketed by markers so you can see whether a block of therapy earned its place in your week.
I have not woken up rested in years. Where do you start?
With measurement, because self-reported sleep is unreliable and the causes separate cleanly once you look. An at-home sleep study, circadian profiling, hormonal panels and respiratory analysis distinguish sleep apnoea from a cortisol rhythm problem from a perimenopausal pattern from simple behavioural drift.
Each of those has a different treatment, and treating the wrong one is how patients end up convinced that nothing helps. Sleep architecture is also one of the fastest markers to respond, which makes it a good early proof that a protocol is working.
My hormones changed the rules. Is this menopause care?
It is broader than that. The woman in transition is often told that her symptoms are ordinary and offered a single prescription or nothing at all. Here, perimenopause and beyond are profiled properly: hormonal panels, bone density, cardiovascular risk, body composition, sleep and mood, read together rather than in isolation.
Treatment is integrative and monitored, including bioidentical hormone therapy where the values, symptoms and risk profile agree. The clinician leading that work is Dr. Erietta Galani, an internal medicine and intensive care physician, and the specific programs each profile typically starts from are listed on the programs and pricing page.